InSilico Medicine Cayman TopCo (O15)
Market Closed
19 Aug, 17:31
XDUS XDUS Primary €
4. 70
+0.12
+2.6201%
€
- Market Cap
- P/E Ratio
- Div Yield
0 Volume
- Eps
€ 4.58
Previous Close Want to track O15 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
InSilico Medicine Cayman TopCo (O15) Statistics
Valuation metrics
Market Cap -
Enterprise value -387.38M
Trailing P/E (ttm) -0.93
Forward P/E -
PEG ratio -
Price/Sales (ttm) -
Price/Book (mrq) -
Enterprise Value/Revenue -6.89
Enterprise Value/EBITDA 1.11
Overview
Shares outstanding 557.42M
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 135
Average volume (90 days) 118
Price summary
52-Week low 3.52
52-Week high 9.04
Beta -
50-Day moving average 6.23
200-Day moving average 6.51
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin 0.82%
Operating margin -6.26%
Operational effectiveness
Return on assets -0.72%
Return on equity -0.78%
Income Statement
Revenue (ttm) 56.24M
Revenue per share (ttm) 0.71
Quarterly revenue growth (yoy) -
Gross profit (ttm) 45.85M
EBITDA -
Net income to common (ttm) -352.32M
Diluted EPS (ttm) -4.48
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 393.34M
Total cash per share (mrq) -
Total debt (mrq) 5.96M
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 13.99%
Book value per share (mrq) -
Cash Flow
Cash flow statement -77.38M
Levered free cash flow (LFCF) -352.32M
